Agentix (AGTX) Cash from Operations (2013 - 2026)
Agentix's (AGTX) quarterly Cash from Operations came in at 14776.0 in Q1 2026, up 134.32% YoY from 6306.0 in Q1 2025, and up 286.14% on a QoQ basis from 7938.0 in Q4 2025.
Agentix (AGTX) Cash from Operations (2013 - 2026) Analysis & Trends
Agentix (AGTX) has 14 years of Cash from Operations data on file, last reported at 14776.0 in Q1 2026.
- Quarterly Cash from Operations rose 134.32% year-over-year to 14776.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 108529.0 (up 13.23% YoY) and the FY2026 annual result came in at 108529.0, up 13.23% from the prior year.
- Cash from Operations improved to 14776.0 in Q1 2026, from 7938.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 55698.0 in Q3 2023 to a low of 118371.0 in Q2 2025.
- A 5-year average of 27036.06 and a median of 22553.5 in 2023 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 217.29% in 2023, down 142738.64% in 2023.
- Tracing AGTX's Cash from Operations over 5 years: stood at 202.0 in 2022, then plunged by 18500.5% to 37169.0 in 2023, then slumped by 134.06% to 86999.0 in 2024, then soared by 90.88% to 7938.0 in 2025, then soared by 286.14% to 14776.0 in 2026.
- The last three Cash from Operations figures came in at 14776.0 (Q1 2026), 7938.0 (Q4 2025), and 3004.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | -26,372.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26,372.00 |
| Jun 30, 2026 | -26,372.00 |
| Mar 31, 2026 | 14,776.00 |
| Mar 31, 2026 | 14,776.00 |
| Dec 31, 2025 | -7,938.00 |
| Dec 31, 2025 | -7,938.00 |
| Sep 30, 2025 | 3,004.00 |
| Sep 30, 2025 | 3,004.00 |
| Jun 30, 2025 | -118,371.00 |
| Jun 30, 2025 | -118,371.00 |
| Mar 31, 2025 | -43,058.00 |
| Mar 31, 2025 | -43,058.00 |
| Dec 31, 2024 | -86,999.00 |
| Dec 31, 2024 | -86,999.00 |
| Sep 30, 2024 | 7,379.00 |
| Sep 30, 2024 | 7,379.00 |
| Jun 30, 2024 | -2,400.00 |
| Jun 30, 2024 | -2,400.00 |
| Mar 31, 2024 | -66,197.00 |
| Mar 31, 2024 | -66,197.00 |